Dr. Hossein Borghaei
Claim this profileFox Chase Cancer Center
Studies Non-Small Cell Lung Cancer
Studies Lung Cancer
11 reported clinical trials
21 drugs studied
Area of expertise
1Non-Small Cell Lung Cancer
Stage IV
Stage III
EGFR positive
2Lung Cancer
Stage IV
Stage III
Stage II
Affiliated Hospitals
Clinical Trials Hossein Borghaei is currently running
Sotorasib
for Non-Small Cell Lung Cancer
This phase II Lung-MAP treatment trial studies the effect of AMG 510 in treating non-squamous non-small cell lung cancer that is stage IV or has come back (recurrent) and has a specific mutation in the KRAS gene, known as KRAS G12C. Mutations in this gene may cause the cancer to grow. AMG 510, a targeted treatment against the KRAS G12C mutation, may help stop the growth of tumor cells.
Recruiting2 awards Phase 219 criteria
Nivolumab + Ramucirumab
for Non-Small Cell Lung Cancer
The study will enroll patients with prior IO therapy (alone or in combination with chemotherapy or in combination with other IO agents) regardless of the PD-L1 level, into a non-randomized combination trial, with primary endpoint of disease control rate.
Recruiting1 award Phase 215 criteria
More about Hossein Borghaei
Clinical Trial Related5 years of experience running clinical trials · Led 11 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Hossein Borghaei has experience with
- Pemetrexed
- Pembrolizumab
- Nivolumab
- Ramucirumab
- Durvalumab
- Carboplatin
Breakdown of trials Hossein Borghaei has run
Non-Small Cell Lung Cancer
Lung Cancer
Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Hossein Borghaei specialize in?
Hossein Borghaei focuses on Non-Small Cell Lung Cancer and Lung Cancer. In particular, much of their work with Non-Small Cell Lung Cancer has involved Stage IV patients, or patients who are Stage III.
Is Hossein Borghaei currently recruiting for clinical trials?
Yes, Hossein Borghaei is currently recruiting for 4 clinical trials in Philadelphia Pennsylvania. If you're interested in participating, you should apply.
Are there any treatments that Hossein Borghaei has studied deeply?
Yes, Hossein Borghaei has studied treatments such as Pemetrexed, Pembrolizumab, Nivolumab.
What is the best way to schedule an appointment with Hossein Borghaei?
Apply for one of the trials that Hossein Borghaei is conducting.
What is the office address of Hossein Borghaei?
The office of Hossein Borghaei is located at: Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111 United States. This is the address for their practice at the Fox Chase Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.